Results 61 to 70 of about 40,516 (197)
Valuing qalys at the end of life [PDF]
There have been changes in the way that NICE evaluates medical treatments for patients who are in the last stages of their lives. If medicines fulfil some criteria to be considered “end of life” NICE considers if QALYs gained under these circumstances ...
Belen Corbacho +2 more
core
QALYs: Are They Enough? a Health Economist's Perspective
John Rawles's criticism of QALYs are seen as being both imprecise and largely unhelpful. This paper accepts that there are problems in both QALYs themselves and in the current decision-making processes which they seek to help.
Mooney, Gavin
core +1 more source
Cost‐effectiveness and impact at scale of collaborative care and lecanemab for Alzheimer's disease
INTRODUCTION Advancements in disease‐modifying therapies and collaborative dementia care programs have created opportunities to transform care for people with Alzheimer's disease.
Kelly J. Atkins +2 more
doaj +1 more source
The independent contribution of executive functions to health related quality of life in older women
Background Cognition is a multidimensional construct and to our knowledge, no previous studies have examined the independent contribution of specific domains of cognition to health related quality of life.
Marra Carlo A +3 more
doaj +1 more source
Toward a Consensus on the QALY
Earlier versions of the other articles in this Value in Health Special Issue, Moving the QALY Forward: Building a Pragmatic Road (articles 2–6) were presented at an ISPOR Development Workshop on “Moving the QALY Forward: Building a Pragmatic Road” held in Philadelphia from November 6–8, 2007.
Drummond, Michael +5 more
openaire +2 more sources
Health care policy evaluation: empirical analysis of the restrictions implied by Quality Adjusted Life Years, CHERE Working Paper 2006/10 [PDF]
This paper investigates the nature of the utility function for health care, defined over the probability of survival, survival duration, health state and cost of treatment.
Elizabeth Savage, Rosalie Viney
core
Background and Aims This study considers the cost‐effectiveness of commonly used cellular, acellular, and matrix‑like products (CAMPs) of human origin also known as human cell and tissue products (HCT/Ps) in the management of diabetic foot ulcers ...
Leo M. Nherera, Jaideep Banerjee
doaj +1 more source
Objective:. This is a preplanned, health economic evaluation from the LIGRO trial. One hundred patients with colorectal liver metastases (CRLM) and standardized future liver remnant
Kristina Hasselgren, MD, PhD +12 more
doaj +1 more source
Preferences, needs and QALYs. [PDF]
Quality Adjusted Life Years (QALYs) have become a household word among health economists. Their use as a means of comparing the value of health programmes and medical interventions has stirred up controversy in the medical profession and the academic community.
openaire +3 more sources
Mean utility values, QALYs and costs per person with dementia.
Mean utility values, QALYs and costs per person with dementia.
Elena Pizzo (5980439) +7 more
core +1 more source

